These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37592963)

  • 1. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.
    Bosserman RE; Farnsworth CW; O'Neil CA; Cass C; Park D; Ballman C; Wallace MA; Struttmann E; Stewart H; Arter O; Peacock K; Fraser VJ; Budge PJ; Olsen MA; Burnham CD; Babcock HM; Kwon JH;
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e133. PubMed ID: 37592963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
    Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Fridkin SK; Collins MH
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1664-1671. PubMed ID: 35156597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.
    Rosser JI; Röltgen K; Dymock M; Shepard J; Martin A; Hogan CA; Blomkalns A; Mathew R; Parsonnet J; Pinsky BA; Maldonado YA; Boyd SD; Chang SI; Holubar M;
    Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1053-1059. PubMed ID: 33292895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
    Self WH; Tenforde MW; Stubblefield WB; Feldstein LR; Steingrub JS; Shapiro NI; Ginde AA; Prekker ME; Brown SM; Peltan ID; Gong MN; Aboodi MS; Khan A; Exline MC; Files DC; Gibbs KW; Lindsell CJ; Rice TW; Jones ID; Halasa N; Talbot HK; Grijalva CG; Casey JD; Hager DN; Qadir N; Henning DJ; Coughlin MM; Schiffer J; Semenova V; Li H; Thornburg NJ; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1221-1226. PubMed ID: 32881855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children's hospital during coronavirus disease 2019 (COVID-19) pandemic.
    Fisher BT; Sharova A; Boge CLK; Gouma S; Kamrin A; Blumenstock J; Shuster S; Gianchetti L; Collins D; Akaho E; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Goodwin EC; Anderson EM; Christensen SR; Balamuth F; John ARO; Li Y; Coffin S; Gerber JS; Hensley SE
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1647-1655. PubMed ID: 34852866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.
    Wilkins JT; Hirschhorn LR; Gray EL; Wallia A; Carnethon M; Zembower TR; Ho J; DeYoung BJ; Zhu A; Rasmussen-Torvik LJ; Taiwo B; Evans CT
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1207-1215. PubMed ID: 34369331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
    Bryan A; Tatem K; Diuguid-Gerber J; Cooke C; Romanoff A; Choudhury N; Scanlon M; Kishore P; Sydney E; Masci J; Bakshi P; Pemmasani S; Davis NJ; Maru D
    BMJ Open; 2021 Nov; 11(11):e053158. PubMed ID: 34732494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.
    Bosserman RE; Farnsworth CW; O'Neil CA; Cass C; Park D; Ballman C; Wallace MA; Struttmann E; Stewart H; Arter O; Peacock K; Fraser VJ; Budge PJ; Olsen MA; Burnham CD; Babcock HM; Kwon JH;
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e93. PubMed ID: 36483363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
    Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
    Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia.
    Caballero N; Nieto MA; Suarez-Zamora DA; Moreno S; Remolina CI; Durán D; Vega D; Rodríguez-Urrego PA; Gómez CP; Rojas DP; Ramírez A; Martínez O; Baldión-Elorza AM; Hernández LJ; Quintero J
    IJID Reg; 2022 Jun; 3():150-156. PubMed ID: 35720138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta.
    Graciaa DS; Kempker RR; Wang YF; Schurr H; Krishnan SD; Carroll K; Toomer L; Merritt S; King D; Hunter M; Rebolledo PA
    Am J Med Sci; 2022 Sep; 364(3):296-303. PubMed ID: 35430255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals.
    Behrens GMN; Cossmann A; Stankov MV; Schulte B; Streeck H; Förster R; Bosnjak B; Willenzon S; Boeck AL; Thu Tran A; Thiele T; Graalmann T; Kayser MZ; Zychlinsky Scharff A; Dopfer C; Horke A; Pink I; Witte T; Wetzke M; Ernst D; Jablonka A; Happle C
    Infect Dis Ther; 2020 Dec; 9(4):837-849. PubMed ID: 32886335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.